HC Wainwright & Co. Reiterates Buy on IN8bio, Announces $8 Price Target

Benzinga · 11/26 11:32
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates IN8bio (NASDAQ:INAB) with a Buy and announces $8 price target.